Raman Spectroscopic Analysis of Bronchoscopic Biopsy for Diagnosing Lung Cancer

China-Japan Friendship Hospital

Status: Not yet enrolling

Conditions: Lung Cancer

Treatments: Diagnostic Test: Raman spectrum

Study type: Interventional

Funder types: Other

Identifiers

NCT05799027

2022-NHLHCRF-LX-01-0201-05

Details and patient eligibility

About

The goal of this clinical trial is to evaluate raman spectroscopic analysis of bronchoscopic biopsy for diagnosing lung cancer in visible lesions in the airway. The main question it aims to answer are: the diagnostic efficacy raman spectroscopic analysis of bronchoscopic biopsy for diagnosing lung cancer.

The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who plan to undergo bronchoscopic biopsy or EBUS-TBNA
• Visible intratracheal lesions under bronchoscope
• Non-visible lesions suspected of lung cancer

Exclusion criteria

• The patient could not tolerate further examination aimed at clarifying the cause of the disease or refused to accept further examination aimed at clarifying the cause of the disease due to poor general condition, serious organ dysfunction, etc
• The patient has no definite diagnosis

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

200 participants in 1 patient group

Raman spectrum analysis

Experimental group

Description:

The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.

Treatment:

Diagnostic Test: Raman spectrum